Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hehlmann

Showing results (111-120 of 310) with videos related to

Pageof 31
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1987
[Bronchoscopic detection of pneumocystis carinii pneumonia]H Dörfler, R Hehlmann, W G Zoller, et al.
Folia Biologica|January 5, 2001
Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term cultureB Schultheis, B Heissig, G Pasternak, et al.
Mycoses|February 18, 2003
Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's diseaseD Buchheidt, A Weiss, S Reiter, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[RNA-tumor-virus-like particles in human melanomas with specific relationship to a melanoma virus in mice]R Hehlmann, B R Balda, J R Cho, et al.
Der Internist|December 16, 2003
[Chronic myeloproliferative diseases. Diagnosis and therapy]E Lengfelder, U Berger, A Reiter, et al.
Annals of Hematology|December 3, 2003
Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemiaU Berger, G Engelich, A Reiter, et al.
International Journal of Cancer|July 15, 1980
Time course of C-type retrovirus expression in mice submitted to osteosarcomagenic doses of 224radiumV Erfle, R Hehlmann, H Schetters, et al.
Annals of Hematology|May 6, 2004
Monitoring of minimal residual disease in acute promyelocytic leukemiaE Lengfelder, A Reiter, S Saussele, et al.
Deutsche Medizinische Wochenschrift (1946)|August 26, 1994
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy]E Lengfelder, M Simon, D Haase, et al.
Blood|May 23, 2001
Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alphaM Schmidt, A Hochhaus, A Nitsche, et al.
Pageof 31

Showing results (111-120 of 310) with videos related to

Sort By:
Pageof 31
Medizinische Klinik (Munich, Germany : 1983)|July 17, 1987
[Bronchoscopic detection of pneumocystis carinii pneumonia]H Dörfler, R Hehlmann, W G Zoller, et al.
Folia Biologica|January 5, 2001
Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term cultureB Schultheis, B Heissig, G Pasternak, et al.
Mycoses|February 18, 2003
Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's diseaseD Buchheidt, A Weiss, S Reiter, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[RNA-tumor-virus-like particles in human melanomas with specific relationship to a melanoma virus in mice]R Hehlmann, B R Balda, J R Cho, et al.
Der Internist|December 16, 2003
[Chronic myeloproliferative diseases. Diagnosis and therapy]E Lengfelder, U Berger, A Reiter, et al.
Annals of Hematology|December 3, 2003
Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemiaU Berger, G Engelich, A Reiter, et al.
International Journal of Cancer|July 15, 1980
Time course of C-type retrovirus expression in mice submitted to osteosarcomagenic doses of 224radiumV Erfle, R Hehlmann, H Schetters, et al.
Annals of Hematology|May 6, 2004
Monitoring of minimal residual disease in acute promyelocytic leukemiaE Lengfelder, A Reiter, S Saussele, et al.
Deutsche Medizinische Wochenschrift (1946)|August 26, 1994
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy]E Lengfelder, M Simon, D Haase, et al.
Blood|May 23, 2001
Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alphaM Schmidt, A Hochhaus, A Nitsche, et al.
Pageof 31